Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-05T07:59:20.871Z Has data issue: false hasContentIssue false
  • English
  • Français

The Delirium Drug Scale is associated to delirium incidence in the emergency department

Published online by Cambridge University Press:  06 December 2017

Patrick Viet-Quoc Nguyen Open the ORCID record for Patrick Viet-Quoc Nguyen [Opens in a new window] ,
Lucie Pelletier ,
Isabelle Payot  and
Judith Latour
Patrick Viet-Quoc Nguyen*
Affiliation:
Department of Pharmacy, Montreal University Hospital Centers (CHUM), Montreal, Quebec, Canada CHUM Research Center, Montreal, Quebec, Canada Réseau Québécois de Recherche en Vieillissement
Lucie Pelletier
Affiliation:
Department of Pharmacy, Montreal University Hospital Centers (CHUM), Montreal, Quebec, Canada
Isabelle Payot
Affiliation:
Department of Geriatrics, Montreal University Hospital Centers (CHUM), Montreal, Quebec, Canada
Judith Latour
Affiliation:
Department of Geriatrics, Montreal University Hospital Centers (CHUM), Montreal, Quebec, Canada
*
Correspondence should be addressed to: Patrick Viet-Quoc Nguyen, Department of Pharmacy, Study conducted at Montreal University Hospital Centers (CHUM), 900 Rue Saint-Denis, Montreal, Quebec, H2X 0A9, Canada. Phone: (+1) 438-876-5074. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The Delirium Drug Scale (DDS) is an evaluation scale developed to assess a patient's drug burden for delirium. The primary goal is to validate the association between the DDS score and the incidence of delirium.

Methods:

This study was an observational retrospective cross-sectional chart review study in patients aged 75 years and older. It was carried out in three emergency departments of a tertiary care university health center. Patients were included if a medication list was available. Delirium present upon admission was assessed during the first five days of admission.

Results:

A total of 1,205 subjects were included in the analysis. The mean age was of 83.4 years, and 62.4% were female. The prevalence of delirium was 19.1%. A total of 745 patients (62%) were exposed to DDS medication. The relative risk for the low (1–2) and high (>2) exposure group according to the DDS score was of 1.26 (CI: 0.95; 1.66) and 2.18 (CI: 1.61; 2.96) compared to a score of 0. In the multivariate analysis, dementia, anxiety, insomnia, history of delirium, infection, and acute kidney failure were significantly associated to delirium. When adjusted for confounding variables, the DDS score was associated with the incidence of delirium with an odd ratio (OR) of 1.29 (CI: 1.16; 1.44).

Conclusions:

This study found that DDS score was associated with delirium incidence. The association persisted in the multivariate analysis adjusted for 26 known risks and precipitating factors for delirium.

Keywords

deliriumagedanticholinergic agentsemergency department
Type
Research Article
Information
International Psychogeriatrics , Volume 30 , Issue 4: Issue Theme: Delirium , April 2018 , pp. 503 - 510
Copyright
Copyright © International Psychogeriatric Association 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association.Google Scholar
American Society of Hospital Pharmacists (2015). AHFS Drug Information. Bethesda, MD: American Society of Hospital Pharmacists.Google Scholar
Best, O., Gnjidic, D., Hilmer, S. N., Naganathan, V. and McLachlan, A. J. (2013). Investigating polypharmacy and drug burden index in hospitalised older people. Internal Medicine Journal, 43, 912–918.CrossRefGoogle ScholarPubMed
Boustani, M., Campbell, N., Munger, S., Maidment, I. and Fox, C. (2008). Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, 4, 311–320.CrossRefGoogle Scholar
Campbell, N., Perkins, A., Hui, S., Khan, B. and Boustani, M. (2011). Association between prescribing of anticholinergic medications and incident delirium: a cohort study. Journal of the American Geriatrics Society, 59, S277–S281.CrossRefGoogle ScholarPubMed
Carnahan, R. M., Lund, B. C., Perry, P. J., Culp, K. R. and Pollock, B. G. (2002). The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents. Psychopharmacol Bull, 36, 14–19.Google ScholarPubMed
Catic, A. G. (2011). Identification and management of in-hospital drug-induced delirium in older patients. Drugs & Aging, 28, 737–748.CrossRefGoogle ScholarPubMed
Durán, C. E., Azermai, M. and Vander Stichele, R. H. (2013). Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology, 69, 1485–1496.CrossRefGoogle ScholarPubMed
Élie, M., Rousseau, F., Cole, M., Primeau, F., McCusker, J. and Bellavance, F. (2000). Prevalence and detection of delirium in elderly emergency department patients. Canadian Medical Association Journal, 163, 977–981.Google ScholarPubMed
Fontova Almató, A., Basurto Oña, X. and Congost Devesa, L. (2012). Prevalencia de delirium en un área de monitorización de urgencias. Revista Española de Geriatría y Gerontología, 47, 39–40.CrossRefGoogle Scholar
Hilmer, S. N. et al. (2007). A drug burden index to define the functional burden of medications in older people. Archives of Internal Medicine, 167, 781–787.CrossRefGoogle ScholarPubMed
Hogan, D. B. et al. (2006). National guidelines for seniors' mental health: the assessment and treatment of delirium. Canadian Journal of Geriatrics, 9, S42–S51.Google Scholar
Hosmer, D. W., Lemeshow, S. and Sturdivant, R. X. (2013). Applied Logistic Regression. Hoboken, New Jersey: Wiley.CrossRefGoogle Scholar
Inouye, S. K., Leo-Summers, L., Zhang, Y., Bogardus, S. T. Jr., Leslie, D. L. and Agostini, J. V. (2005). A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment method. Journal of the American Geriatrics Society, 53, 312–318.CrossRefGoogle ScholarPubMed
Inouye, S. K., Westendorp, R. G. and Saczynski, J. S. (2014). Delirium in elderly people. Lancet, 383, 911–922.CrossRefGoogle ScholarPubMed
Jackson, T. A., Wilson, D., Richardson, S. and Lord, J. M. (2016). Predicting outcome in older hospital patients with delirium: a systematic literature review. International Journal of Geriatric Psychiatry, 31, 392–399.CrossRefGoogle ScholarPubMed
Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D. and Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatrics Society, 62, 1916–1922.CrossRefGoogle ScholarPubMed
Kennedy, M., Enander, R. A., Tadiri, S. P., Wolfe, R. E., Shapiro, N. I. and Marcantonio, E. R. (2014). Delirium risk prediction, healthcare use and mortality of elderly adults in the emergency department. Journal of the American Geriatrics Society, 62, 462–469.CrossRefGoogle ScholarPubMed
Landi, F. et al. (2014). Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. Journal of the American Medical Directors Association, 15, 825–829.CrossRefGoogle ScholarPubMed
Midlov̈, P., Eriksson, T. and Kragh, A. (2009). Drug-Related Problems in the Elderly. Dordrecht: Springer.CrossRefGoogle Scholar
Naples, J. G. et al. (2015). Concordance between Anticholinergic Burden Scales. Journal of the American Geriatrics Society, 63, 2120–2124.CrossRefGoogle ScholarPubMed
Nguyen, P., Pelletier, L., Payot, I. and Latour, J. (2016). Drug Delirium Scale (DDS): a tool to evaluate drugs as a risk factor for Delirium. International Journal of Innovative Research in Medical Science, 1, 232–237.Google Scholar
Rudolph, J. L., Salow, M. J., Angelini, M. C. and McGlinchey, R. E. (2008). The anticholinergic risk scale and anticholinergic adverse effects in older persons. Archives of Internal Medicine, 168, 508–513.CrossRefGoogle ScholarPubMed
Trzepacz, P. T. and Meagher, D. J. (2007). Neuropsychiatric aspects of Delirium. In Yudofsky, S. C. and Hales, R. E. (Eds.), American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Neurosciences, 5th edn. (pp. 445–503). Washington: American Psychiatric Publication.Google Scholar
Wehling, M. (2013). Drug Therapy for the Elderly. Wien; New York: Springer.CrossRefGoogle Scholar
Witlox, J., Eurelings, L. M., de Jonghe, J. M., Kalisvaart, K. J., Eikelenboom, P. and van Gool, W. A. (2010). Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. Journal of the American Medical Association, 304, 443–451.CrossRefGoogle ScholarPubMed